|
S&P BIOTECHNOLOGY SELECT INDUSTRY INDEX ... |
|
20.29% |
|
|
|
|
|
|
|
|
|
|---|
| NBIX |
Neurocrine Biosciences, Inc. |
0 |
0.57% |
|
|
|
|
|
N/A |
0.00% |
27.77% |
8.48% |
|---|
| ABBV |
AbbVie Inc. |
0 |
0.54% |
|
|
|
|
|
N/A |
0.00% |
24.36% |
14.55% |
|---|
| GILD |
Gilead Sciences, Inc. |
0 |
0.54% |
|
|
|
|
|
N/A |
0.00% |
29.35% |
27.52% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
0 |
0.54% |
|
|
|
|
|
N/A |
0.00% |
39.49% |
50.37% |
|---|
| UTHR |
United Therapeutics Corporation |
0 |
0.52% |
|
|
|
|
|
N/A |
0.00% |
58.67% |
104.61% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
0 |
0.51% |
|
|
|
|
|
N/A |
0.00% |
117.60% |
53.76% |
|---|
| AMGN |
Amgen Inc. |
0 |
0.51% |
|
|
|
|
|
N/A |
0.00% |
27.10% |
20.21% |
|---|
| BIIB |
Biogen Inc. |
0 |
0.51% |
|
|
|
|
|
N/A |
0.00% |
28.33% |
18.82% |
|---|
| NTRA |
Natera, Inc. |
0 |
0.51% |
|
|
|
|
|
N/A |
0.00% |
53.38% |
31.33% |
|---|
| INCY |
Incyte Corporation |
0 |
0.50% |
|
|
|
|
|
N/A |
0.00% |
29.49% |
27.75% |
|---|
| INSM |
Insmed Incorporated |
0 |
0.50% |
|
|
|
|
|
N/A |
0.00% |
72.86% |
66.33% |
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
0 |
0.49% |
|
|
|
|
|
N/A |
0.00% |
33.44% |
22.47% |
|---|
| MRNA |
Moderna, Inc. |
0 |
0.49% |
|
|
|
|
|
N/A |
0.00% |
56.54% |
10.47% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
0 |
0.49% |
|
|
|
|
|
N/A |
0.00% |
35.99% |
35.90% |
|---|
| EXAS |
Exact Sciences Corporation |
0 |
0.48% |
|
|
|
|
|
N/A |
0.00% |
61.77% |
68.33% |
|---|
| PCVX |
Vaxcyte, Inc. |
0 |
0.47% |
|
|
|
|
|
N/A |
0.00% |
77.99% |
47.74% |
|---|
| VRTX |
Vertex Pharmaceuticals Incorporated |
0 |
0.46% |
|
|
|
|
|
N/A |
0.00% |
35.91% |
45.64% |
|---|
| VKTX |
Viking Therapeutics, Inc. |
0 |
0.44% |
|
|
|
|
|
N/A |
0.00% |
121.82% |
74.64% |
|---|
| TGTX |
TG Therapeutics, Inc. |
0 |
0.42% |
|
|
|
|
|
N/A |
0.00% |
59.24% |
44.72% |
|---|
| HALO |
Halozyme Therapeutics, Inc. |
0 |
0.41% |
|
|
|
|
|
N/A |
0.00% |
42.17% |
37.99% |
|---|
| MDGL |
Madrigal Pharmaceuticals, Inc. |
0 |
0.41% |
|
|
|
|
|
N/A |
0.00% |
61.24% |
39.57% |
|---|
| ADMA |
ADMA Biologics, Inc. |
0 |
0.35% |
|
|
|
|
|
N/A |
0.00% |
65.73% |
38.96% |
|---|
| IONS |
Ionis Pharmaceuticals, Inc. |
0 |
0.34% |
|
|
|
|
|
N/A |
0.00% |
46.53% |
42.27% |
|---|
| ROIV |
Roivant Sciences Ltd. |
0 |
0.33% |
|
|
|
|
|
N/A |
0.00% |
33.05% |
49.22% |
|---|
| BPMC |
Blueprint Medicines Corporation |
0 |
0.31% |
|
|
|
|
|
N/A |
0.00% |
94.29% |
1.14% |
|---|
| APLS |
Apellis Pharmaceuticals, Inc. |
0 |
0.31% |
|
|
|
|
|
N/A |
0.00% |
49.58% |
6.95% |
|---|
| CYTK |
Cytokinetics, Incorporated |
0 |
0.31% |
|
|
|
|
|
N/A |
0.00% |
79.89% |
34.47% |
|---|
| RVMD |
Revolution Medicines, Inc. |
0 |
0.30% |
|
|
|
|
|
N/A |
0.00% |
54.00% |
42.22% |
|---|
| EXEL |
Exelixis, Inc. |
0 |
0.28% |
|
|
|
|
|
N/A |
0.00% |
32.60% |
25.01% |
|---|
| BBIO |
BridgeBio Pharma, Inc. |
0 |
0.28% |
|
|
|
|
|
N/A |
0.00% |
64.17% |
24.99% |
|---|
| CRSP |
CRISPR Therapeutics AG |
0 |
0.26% |
|
|
|
|
|
N/A |
0.00% |
57.68% |
34.39% |
|---|
| ALKS |
Alkermes plc |
0 |
0.24% |
|
|
|
|
|
N/A |
0.00% |
58.11% |
42.47% |
|---|
| SMMT |
Summit Therapeutics Inc. |
0 |
0.22% |
|
|
|
|
|
N/A |
0.00% |
82.88% |
23.35% |
|---|
| ACLX |
Arcellx, Inc. |
0 |
0.22% |
|
|
|
|
|
N/A |
0.00% |
50.16% |
23.91% |
|---|
| RNA |
Avidity Biosciences, Inc. |
0 |
0.21% |
|
|
|
|
|
N/A |
0.00% |
107.70% |
69.67% |
|---|
| BHVN |
Biohaven Pharmaceutical Holding Company ... |
0 |
0.20% |
|
|
|
|
|
N/A |
0.00% |
113.49% |
70.46% |
|---|
| NUVL |
Nuvalent, Inc. |
0 |
0.19% |
|
|
|
|
|
N/A |
0.00% |
46.28% |
35.21% |
|---|
| TWST |
Twist Bioscience Corporation |
0 |
0.18% |
|
|
|
|
|
N/A |
0.00% |
71.14% |
41.48% |
|---|
| SWTX |
SPRINGWORKS THERAPEUTICS INC |
|
0.18% |
|
|
|
|
|
|
|
|
|
|---|
| RARE |
Ultragenyx Pharmaceutical Inc. |
0 |
0.17% |
|
|
|
|
|
N/A |
0.00% |
57.42% |
15.18% |
|---|
| RXRX |
Recursion Pharmaceuticals, Inc. |
0 |
0.17% |
|
|
|
|
|
N/A |
0.00% |
196.89% |
54.10% |
|---|
| KRYS |
Krystal Biotech, Inc. |
0 |
0.17% |
|
|
|
|
|
N/A |
0.00% |
57.07% |
59.43% |
|---|
| CRNX |
Crinetics Pharmaceuticals, Inc. |
0 |
0.17% |
|
|
|
|
|
N/A |
0.00% |
45.83% |
31.48% |
|---|
| IOVA |
Iovance Biotherapeutics, Inc. |
0 |
0.16% |
|
|
|
|
|
N/A |
0.00% |
446.29% |
27.56% |
|---|
| GERN |
Geron Corporation |
0 |
0.16% |
|
|
|
|
|
N/A |
0.00% |
354.23% |
31.50% |
|---|
| DYN |
Dyne Therapeutics, Inc. |
0 |
0.16% |
|
|
|
|
|
N/A |
0.00% |
262.17% |
35.70% |
|---|
| CLDX |
Celldex Therapeutics, Inc. |
0 |
0.15% |
|
|
|
|
|
N/A |
0.00% |
88.72% |
52.03% |
|---|
| PTGX |
Protagonist Therapeutics, Inc. |
0 |
0.15% |
|
|
|
|
|
N/A |
0.00% |
45.69% |
7.98% |
|---|
| VERA |
Vera Therapeutics, Inc. |
0 |
0.14% |
|
|
|
|
|
N/A |
0.00% |
124.19% |
23.60% |
|---|
| VCYT |
Veracyte, Inc. |
0 |
0.14% |
|
|
|
|
|
N/A |
0.00% |
74.15% |
18.96% |
|---|
| PTCT |
PTC Therapeutics, Inc. |
0 |
0.14% |
|
|
|
|
|
N/A |
0.00% |
65.50% |
40.18% |
|---|
| SRRK |
Scholar Rock Holding Corporation |
0 |
0.14% |
|
|
|
|
|
N/A |
0.00% |
66.90% |
7.26% |
|---|
| VRDN |
Viridian Therapeutics, Inc. |
0 |
0.13% |
|
|
|
|
|
N/A |
0.00% |
1,145.17% |
23.65% |
|---|
| DVAX |
Dynavax Technologies Corporation |
0 |
0.13% |
|
|
|
|
|
N/A |
0.00% |
166.51% |
33.05% |
|---|
| FOLD |
Amicus Therapeutics, Inc. |
0 |
0.13% |
|
|
|
|
|
N/A |
0.00% |
833.65% |
48.16% |
|---|
| NTLA |
Intellia Therapeutics, Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
92.06% |
42.42% |
|---|
| TVTX |
Travere Therapeutics, Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
1,029.44% |
4.35% |
|---|
| ARQT |
Arcutis Biotherapeutics, Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
88.08% |
44.45% |
|---|
| IDYA |
IDEAYA Biosciences, Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
225.35% |
14.69% |
|---|
| NVAX |
Novavax, Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
322.77% |
18.68% |
|---|
| SLNO |
Soleno Therapeutics, Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
56.83% |
19.13% |
|---|
| BEAM |
Beam Therapeutics Inc. |
0 |
0.12% |
|
|
|
|
|
N/A |
0.00% |
66.94% |
41.18% |
|---|
| DNLI |
Denali Therapeutics Inc. |
0 |
0.11% |
|
|
|
|
|
N/A |
0.00% |
681.57% |
28.25% |
|---|
| IMVT |
Immunovant, Inc. |
0 |
0.11% |
|
|
|
|
|
N/A |
0.00% |
112.32% |
38.97% |
|---|
| JANX |
Janux Therapeutics, Inc. |
0 |
0.11% |
|
|
|
|
|
N/A |
0.00% |
90.33% |
49.69% |
|---|
| ARDX |
Ardelyx, Inc. |
0 |
0.11% |
|
|
|
|
|
N/A |
0.00% |
87.47% |
46.97% |
|---|
| RYTM |
Rhythm Pharmaceuticals, Inc. |
0 |
0.11% |
|
|
|
|
|
N/A |
0.00% |
49.35% |
16.68% |
|---|
| APGE |
Apogee Therapeutics, Inc. |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
78.18% |
8.72% |
|---|
| PRAX |
Praxis Precision Medicines, Inc. |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
179.58% |
73.91% |
|---|
| ARWR |
Arrowhead Pharmaceuticals, Inc. |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
75.44% |
34.69% |
|---|
| ACAD |
ACADIA Pharmaceuticals Inc. |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
435.76% |
49.91% |
|---|
| CDNA |
CareDx, Inc |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
99.20% |
49.73% |
|---|
| CPRX |
Catalyst Pharmaceuticals, Inc. |
0 |
0.10% |
|
|
|
|
|
N/A |
0.00% |
53.58% |
49.52% |
|---|
| VCEL |
Vericel Corporation |
0 |
0.09% |
|
|
|
|
|
N/A |
0.00% |
67.79% |
66.63% |
|---|
| CGON |
CG Oncology, Inc. Common stock |
0 |
0.09% |
|
|
|
|
|
N/A |
0.00% |
185.01% |
21.54% |
|---|
| AGIO |
Agios Pharmaceuticals, Inc. |
0 |
0.09% |
|
|
|
|
|
N/A |
0.00% |
50.34% |
51.96% |
|---|
| KYMR |
Kymera Therapeutics, Inc. |
0 |
0.09% |
|
|
|
|
|
N/A |
0.00% |
72.71% |
31.33% |
|---|
| SNDX |
Syndax Pharmaceuticals, Inc. |
0 |
0.09% |
|
|
|
|
|
N/A |
0.00% |
152.47% |
41.01% |
|---|
| MYGN |
Myriad Genetics, Inc. |
0 |
0.09% |
|
|
|
|
|
N/A |
0.00% |
809.33% |
102.56% |
|---|
| NRIX |
Nurix Therapeutics, Inc. |
0 |
0.09% |
|
|
|
|
|
N/A |
0.00% |
285.85% |
33.99% |
|---|
| MNKD |
MannKind Corporation |
0 |
0.08% |
|
|
|
|
|
N/A |
0.00% |
351.89% |
83.68% |
|---|
| AKRO |
Akero Therapeutics, Inc. |
0 |
0.08% |
|
|
|
|
|
N/A |
0.00% |
73.12% |
19.29% |
|---|
| DAWN |
Day One Biopharmaceuticals, Inc. |
0 |
0.08% |
|
|
|
|
|
N/A |
0.00% |
603.44% |
78.76% |
|---|
| MIRM |
Mirum Pharmaceuticals, Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
133.27% |
40.59% |
|---|
| RCKT |
Rocket Pharmaceuticals, Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
173.45% |
70.73% |
|---|
| BCRX |
BioCryst Pharmaceuticals, Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
63.62% |
80.33% |
|---|
| SYRE |
Spyre Therapeutics, Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
1,064.59% |
26.63% |
|---|
| CAPR |
Capricor Therapeutics, Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
240.97% |
71.74% |
|---|
| IRON |
Disc Medicine, Inc. |
0 |
0.07% |
|
|
|
|
|
N/A |
0.00% |
64.73% |
11.25% |
|---|
| IBRX |
ImmunityBio, Inc. |
0 |
0.06% |
|
|
|
|
|
N/A |
0.00% |
123.91% |
54.84% |
|---|
| SPRY |
ARS Pharmaceuticals, Inc. |
0 |
0.06% |
|
|
|
|
|
N/A |
0.00% |
82.70% |
18.25% |
|---|
| CDMO |
AVID BIOSERVICES INC |
|
0.05% |
|
|
|
|
|
|
|
|
|
|---|
| HUMA |
Humacyte, Inc. |
0 |
0.05% |
|
|
|
|
|
N/A |
0.00% |
109.85% |
26.96% |
|---|
| KURA |
Kura Oncology, Inc. |
0 |
0.05% |
|
|
|
|
|
N/A |
0.00% |
578.10% |
53.74% |
|---|
| XNCR |
Xencor, Inc. |
0 |
0.05% |
|
|
|
|
|
N/A |
0.00% |
155.10% |
39.62% |
|---|
| COGT |
Cogent Biosciences, Inc. |
0 |
0.05% |
|
|
|
|
|
N/A |
0.00% |
164.12% |
20.30% |
|---|
| ALT |
Altimmune, Inc. |
0 |
0.05% |
|
|
|
|
|
N/A |
0.00% |
N/A |
-1.21% |
|---|
| EBS |
Emergent BioSolutions Inc. |
0 |
0.05% |
|
|
|
|
|
N/A |
0.00% |
744.73% |
26.35% |
|---|
| RCUS |
Arcus Biosciences, Inc. |
0 |
0.05% |
|
|
|
|
|
N/A |
0.00% |
541.51% |
49.96% |
|---|